Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
10/18/2024 | CALL | $5.00 | 245 | +101 | +70.14% |
10/18/2024 | CALL | $2.50 | 1 | 0 | |
10/18/2024 | CALL | $7.50 | 92 | 0 | |
10/18/2024 | CALL | $10.00 | 0 | 0 | |
10/18/2024 | PUT | $2.50 | 20 | 0 | |
10/18/2024 | PUT | $5.00 | 533 | 0 | |
05/16/2025 | CALL | $7.50 | 0 | 0 | |
05/16/2025 | CALL | $10.00 | 0 | 0 | |
05/16/2025 | PUT | $2.50 | 0 | 0 | |
05/16/2025 | PUT | $5.00 | 0 | 0 | |
05/16/2025 | PUT | $7.50 | 0 | 0 | |
05/16/2025 | PUT | $10.00 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Thyroid Eye Disease Market to Accelerate Substantially by 2034, Assesses DelveInsight | Key Companies Developing ... - GlobeNewswire
07/04 04:01 pm
GlobeNewswire Inc.
Read moreACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
05/09 08:01 am
GlobeNewswire Inc.
Read moreACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024
04/29 04:05 pm
GlobeNewswire Inc.
Read moreACELYRIN (SLRN) Up on Data From Thyroid Eye Disease Study
03/21 11:12 am
Zacks Investment Research
Read moreACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
03/11 08:02 am
GlobeNewswire Inc.
Read moreACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications
02/15 05:05 pm
GlobeNewswire Inc.
Read moreACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
12/20 05:30 pm
GlobeNewswire Inc.
Read moreWhat 5 Analyst Ratings Have To Say About Acelyrin
11/28 09:00 am
Benzinga
Read moreACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
11/27 05:30 pm
GlobeNewswire Inc.
Read moreAcelyrin (SLRN) Q3 2023 Earnings Call Transcript
11/07 10:45 pm
The Motley Fool
Read moreACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights
11/07 05:05 pm
GlobeNewswire Inc.
Read moreACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023
10/31 04:30 pm
GlobeNewswire Inc.
Read moreWhy Acelyrin Stock Plummeted 59% This Week
09/15 05:39 pm
The Motley Fool
Read moreBenzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
09/13 11:00 am
Benzinga
Read moreACELYRIN (SLRN) Fails to Meet Goal in HS Study, Stock Down 54%
09/13 09:45 am
Zacks Investment Research
Read moreDespite Trial Setback For Acelyrin's Lead Program, Analyst Shows Optimism
09/12 02:57 pm
Benzinga
Read moreWhy CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
09/12 01:44 pm
Benzinga
Read moreDow Falls 75 Points; US Small Business Optimism Drops In August
09/12 09:59 am
Benzinga
Read moreOracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
09/12 05:40 am
Benzinga
Read moreACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
09/11 04:05 pm
GlobeNewswire Inc.
Read moreACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
09/06 07:00 am
GlobeNewswire Inc.
Read moreBenzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
09/05 11:00 am
Benzinga
Read moreSkin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
08/31 01:38 pm
Benzinga
Read morePaysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
08/15 10:42 am
Benzinga
Read moreAcelyrin (SLRN) Q2 2023 Earnings Call Transcript
08/14 11:30 pm
The Motley Fool
Read moreACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights
08/14 04:05 pm
GlobeNewswire Inc.
Read moreACELYRIN, INC. to Present Second Quarter 2023 Financial Results and Corporate Update on August 14, 2023
08/07 04:30 pm
GlobeNewswire Inc.
Read moreACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer
07/18 07:00 am
GlobeNewswire Inc.
Read moreWolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
06/26 10:13 am
Benzinga
Read moreUS Stocks Edge Higher; Goldman Sachs Downgrades Tesla To Neutral
06/26 09:44 am
Benzinga
Read moreACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights
06/15 04:05 pm
GlobeNewswire Inc.
Read moreBenzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
05/30 11:00 am
Benzinga
Read moreWall Street Breakfast: The Week Ahead
05/28 07:30 am
Seeking Alpha
Read more